You can buy or sell electroCore and other stocks, options, ETFs, and crypto commission-free!
electroCore, Inc. Common Stock, also called electroCore, is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. Read More The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
Basking Ridge, New Jersey
52 Week High
52 Week Low
Yahoo FinanceMay 8
electroCore to Announce First Quarter 2019 Financial Results on Tuesday, May 14
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, announced that it will report first quarter ended March 31, 2019 financial results after the close of the market on Tuesday May 14, 2019. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions. Tuesday, May 14 @ 4:30pm Eastern Time Domestic: 877-407-4018...
-$0.54 per share
-$0.47 per share